CR7039A - Modificacion cristalina de un depsipeptido ciclico con actividad mejorada - Google Patents

Modificacion cristalina de un depsipeptido ciclico con actividad mejorada

Info

Publication number
CR7039A
CR7039A CR7039A CR7039A CR7039A CR 7039 A CR7039 A CR 7039A CR 7039 A CR7039 A CR 7039A CR 7039 A CR7039 A CR 7039A CR 7039 A CR7039 A CR 7039A
Authority
CR
Costa Rica
Prior art keywords
cyclic depsipeptide
improved activity
crystal modification
depsipeptide
cyclic
Prior art date
Application number
CR7039A
Other languages
English (en)
Inventor
Kalbe Jochen
Traebuel Michael
Harder Achim
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of CR7039A publication Critical patent/CR7039A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invencion se refiere al empleo de la modificacion cristalina (I) del depsipeptido ciclico de la formula (I) para la obtencion de medicamentos, especialmente para la lucha contra endoparasitos.
CR7039A 2001-02-01 2003-07-30 Modificacion cristalina de un depsipeptido ciclico con actividad mejorada CR7039A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10104362A DE10104362A1 (de) 2001-02-01 2001-02-01 Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit

Publications (1)

Publication Number Publication Date
CR7039A true CR7039A (es) 2004-06-08

Family

ID=7672376

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7039A CR7039A (es) 2001-02-01 2003-07-30 Modificacion cristalina de un depsipeptido ciclico con actividad mejorada

Country Status (27)

Country Link
US (1) US20040115483A1 (es)
EP (1) EP1357932B1 (es)
JP (1) JP2004525111A (es)
KR (2) KR20030081378A (es)
CN (1) CN1278735C (es)
AT (1) ATE284703T1 (es)
AU (1) AU2002226415B2 (es)
BR (1) BRPI0206841B8 (es)
CA (1) CA2436832C (es)
CR (1) CR7039A (es)
CZ (1) CZ299564B6 (es)
DE (2) DE10104362A1 (es)
EE (1) EE05490B1 (es)
ES (1) ES2233805T3 (es)
HR (1) HRP20030635A2 (es)
HU (1) HU229229B1 (es)
IL (2) IL157026A0 (es)
MX (1) MXPA03006866A (es)
NO (1) NO331289B1 (es)
NZ (1) NZ527230A (es)
PL (1) PL213106B1 (es)
PT (1) PT1357932E (es)
RU (1) RU2300390C2 (es)
SK (1) SK286280B6 (es)
UA (1) UA74623C2 (es)
WO (1) WO2002066048A1 (es)
ZA (1) ZA200305864B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080003546A1 (en) * 2006-06-29 2008-01-03 Dunbar Kimberly L Animated digital charted yarncraft instruction
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
BR112018013369A2 (pt) 2015-12-28 2019-02-19 Merial, Inc. compostos depsipeptídicos anti-helmínticos
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN114262303A (zh) * 2022-01-04 2022-04-01 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型ii及其制备方法
CN114989110A (zh) * 2022-07-13 2022-09-02 丽珠集团福州福兴医药有限公司 单晶型ⅳ的艾默德斯及其制备方法
CN115010680A (zh) * 2022-07-13 2022-09-06 丽珠集团福州福兴医药有限公司 单晶型i的艾默德斯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2096907A (en) * 1981-04-22 1982-10-27 Exxon Research Engineering Co Distillation column with steam stripping
NZ249588A (en) * 1992-03-17 1996-08-27 Fujisawa Pharmaceutical Co Anthelmintic agent
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
ATE425973T1 (de) * 1995-06-30 2009-04-15 Astellas Pharma Inc Depsipeptid-derivat, verfahren zu dessen herstellung und zwischenprodukt dafur
ATE299871T1 (de) * 1995-09-22 2005-08-15 Meiji Seika Kaisha Neue zyklische depsipeptid pf1022 derivate
NZ504812A (en) * 1997-11-10 2002-08-28 Fujisawa Pharmaceutical Co A crystal of a phenyl-morpholino substituted depsipeptide derivative
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere

Also Published As

Publication number Publication date
WO2002066048A8 (de) 2003-11-20
IL157026A (en) 2010-11-30
NO331289B1 (no) 2011-11-21
MXPA03006866A (es) 2004-05-31
PT1357932E (pt) 2005-04-29
CN1592631A (zh) 2005-03-09
AU2002226415B2 (en) 2007-03-22
KR20030081378A (ko) 2003-10-17
ES2233805T3 (es) 2005-06-16
SK9882003A3 (en) 2003-12-02
CZ20032063A3 (cs) 2003-11-12
UA74623C2 (en) 2006-01-16
CA2436832A1 (en) 2002-08-29
DE10104362A1 (de) 2002-08-08
EE200300365A (et) 2003-10-15
BRPI0206841B8 (pt) 2021-05-25
NO20033413D0 (no) 2003-07-30
CA2436832C (en) 2013-06-11
HUP0302880A2 (hu) 2003-12-29
WO2002066048A1 (de) 2002-08-29
ZA200305864B (en) 2004-08-27
SK286280B6 (sk) 2008-06-06
RU2003126589A (ru) 2005-02-27
BR0206841A (pt) 2004-02-25
JP2004525111A (ja) 2004-08-19
HRP20030635A2 (en) 2005-10-31
PL362389A1 (en) 2004-11-02
EP1357932B1 (de) 2004-12-15
CN1278735C (zh) 2006-10-11
ATE284703T1 (de) 2005-01-15
KR20090041451A (ko) 2009-04-28
EE05490B1 (et) 2011-12-15
HU229229B1 (en) 2013-09-30
HK1075013A1 (en) 2005-12-02
DE50201777D1 (de) 2005-01-20
RU2300390C2 (ru) 2007-06-10
HUP0302880A3 (en) 2005-05-30
NO20033413L (no) 2003-09-26
BRPI0206841B1 (pt) 2018-02-14
PL213106B1 (pl) 2013-01-31
EP1357932A1 (de) 2003-11-05
CZ299564B6 (cs) 2008-09-03
NZ527230A (en) 2005-04-29
US20040115483A1 (en) 2004-06-17
IL157026A0 (en) 2004-02-08

Similar Documents

Publication Publication Date Title
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
BRPI0418181A (pt) emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
CR7039A (es) Modificacion cristalina de un depsipeptido ciclico con actividad mejorada
TR200003156T2 (tr) Bir aktif içerik olarak izomalt içeren terapötik soğuk algınlığına karşı ajan.
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
SE0303480D0 (sv) Benzofuranes
SE0200198D0 (sv) New use
NO20080079L (no) AMPA-reseptorpotensiatorer
BR0016942A (pt) Derivados substituìdos de aminometil-fenil-ciclohexano
DK1250337T3 (da) Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter
GB2358137B (en) Compound
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
ECSP034713A (es) Sales de adicion de acido malico de terbinafina
DE602004015972D1 (en) Depigmentierungsmittel
ATE328595T1 (de) Carvedilolpolymorph
CR9435A (es) Uso de un compuesto
UY26979A1 (es) Nuevos derivados de piranosido
SE0401716D0 (sv) New compounds
HN2002000331A (es) Composiciones farmaceuticas de 5,7,14-triazatetra-ciclo (10.3.1.02,11.04,9)-hexadeca-2(11) 3,5,7,9-pentaeno